Home › Funds › Campbell & CO Investment Adviser LLC › UTHR

Campbell & CO Investment Adviser LLC position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

Campbell & CO Investment Adviser LLC reported holding 18,114 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$9.8M, representing 0.42% of its reported portfolio and ranking #33 among its reported holdings. Campbell & CO Investment Adviser LLC has disclosed UTHR holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)18.11K sh
Reported value held$9.82M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Campbell & CO Investment Adviser LLC's UTHR position evolved

Campbell & CO Investment Adviser LLC first disclosed a stake in UTHR in Q3 2023 at 3,125 shares (US$706K). The position peaked in Q3 2026 at 18,114 shares, worth US$9.8M. Across 9 filings, Campbell & CO Investment Adviser LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 18,114 shares valued at US$9.8M — an increase of 4,805 shares quarter over quarter.. Notable position changes include a 164% increase in Q4 2023 (shares rose 4% over the following quarter), a 45% trim in Q2 2025 (shares rose 46% over the following quarter), a 107% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.12K $705.84K New
Q4 2023 8.24K $1.81M Add
Q1 2024 5.93K $1.36M Reduce
Q3 2024 1.04K $373.76K New
Q1 2025 7.50K $2.31M New
Q2 2025 4.14K $1.19M Reduce
Q1 2026 6.43K $3.82M New
Q2 2026 13.31K $7.21M Add
Q3 2026 18.11K $9.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has Campbell & CO Investment Adviser LLC held UTHR?

Campbell & CO Investment Adviser LLC has disclosed UTHR holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is Campbell & CO Investment Adviser LLC's current position in UTHR?

As of Q3 2026, Campbell & CO Investment Adviser LLC holds 18.11K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $9.82M, representing 0.42% of its reported portfolio and ranking #33.

Has Campbell & CO Investment Adviser LLC been buying or selling UTHR?

In the latest 13F filing (Q3 2026), Campbell & CO Investment Adviser LLC increased its position in UTHR. The position peaked in Q3 2026 at 18.11K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.